If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

Share Price is delayed by 15 minutes
Get Live Data
8.60    -0.20 (-2.27%)
Bid:
8.30
Ask:
8.90
Spread: 0.60 (7.229%)
Market Cap: £56.36m
KMK Live PriceLast checked at - London Stock Exchange

Intraday Kromek Share Chart

Director Share Purchases

12 Dec 2019 07:00

RNS Number : 5921W
Kromek Group PLC
12 December 2019
 

12 December 2019

 

Kromek Group plc

("Kromek" the "Company" or the "Group")

 

Director Share Purchases

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security and civil nuclear markets, announces that Sir Peter Williams, Chairman, Dr Arnab Basu, Chief Executive Officer, and Mr Derek Bulmer, Chief Financial Officer, yesterday purchased ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as follows:

 

Name

Title

Number of Ordinary Shares purchased

Price paid per share (pence)

Resulting shareholding

Percentage of issued share capital 

Sir Peter Williams

Chairman

50,000

22.50

200,000

0.06%

Dr Arnab Basu

Chief Executive Officer

20,000

17.95

2,972,000

0.86%

Mr Derek Bulmer

Chief Financial Officer

20,000

17.94

132,292

0.04%

 

 

For further information, please contact:

Kromek Group plc

Arnab Basu, CEODerek Bulmer, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

Max Hartley (NOMAD)Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

Harry ChathliClaire NorburyAlexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

1. Sir Peter Williams

2. Dr Arnab Basu

3. Derek Bulmer

 

2

Reason for the notification

a)

Position/status

1. Chairman

2. Chief Executive Officer

3. Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Kromek Group plc

b)

LEI

213800VLHYXGHEX5VQ48

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BD7V5D43

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

1. 22.50p

2. 17.95p

3. 17.94p

1. 50,000

2. 20,000

3. 20,000

 

d)

Aggregated information

- Aggregated volume- Price

 

 N/A

e)

Date of the transaction

11 December 2019

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHTBBBTMBMBTAL
Date   Source Headline
14th Feb 20175:39 pmRNSHolding(s) in Company
14th Feb 20175:25 pmRNSDirector/PDMR Shareholding
14th Feb 20172:27 pmRNSHolding(s) in Company
14th Feb 201710:31 amRNSHolding(s) in Company
13th Feb 20172:04 pmRNSDirector/PDMR Shareholding
10th Feb 20173:19 pmRNSDirector/PDMR Shareholding
10th Feb 201711:51 amRNSResults of Firm Placing, Open Offer and GM
2nd Feb 20174:38 pmRNSHolding(s) in Company
1st Feb 20175:18 pmRNSHolding(s) in Company
26th Jan 201711:42 amRNSHolding(s) in Company
25th Jan 20177:00 amRNSFirm Placing and Open Offer to raise up to £21m
24th Jan 201710:15 amRNSTotal Voting Rights
22nd Dec 201611:05 amRNSSecond Price Monitoring Extn
22nd Dec 201611:00 amRNSPrice Monitoring Extension
7th Dec 20167:00 amRNSInterim Results
24th Nov 20162:15 pmRNSHolding(s) in Company
18th Nov 201612:15 pmRNSNotice of Results
2nd Nov 20167:00 amRNSNew BMD orders from existing OEM customers
19th Oct 20167:00 amRNSDelivery of 10,000 units of D3S to DARPA
17th Oct 20167:00 amRNSSix New Contract Wins Across All Business Segments
30th Sep 201612:22 pmRNSBlock listing Interim Review
21st Sep 201612:33 pmRNSResult of AGM
9th Sep 201611:46 amRNSBlock Admission
26th Aug 20163:24 pmRNSNotice of AGM and Posting of Annual Report
3rd Aug 20164:13 pmRNSHolding(s) in Company
1st Aug 20161:09 pmRNSPublication of Annual Report
29th Jul 201612:37 pmRNSTotal Voting Rights
20th Jul 201610:06 amRNSDirector/PDMR Shareholding
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSHolding(s) in Company
28th Apr 20167:00 amRNSNew $12.6m contract with existing OEM customer
15th Apr 20161:27 pmRNSTotal Voting Rights
15th Apr 20161:25 pmRNSBlock listing Interim Review
14th Mar 20167:00 amRNSDirector Share Purchase
25th Feb 201611:12 amRNSHolding(s) in Company
22nd Feb 20167:00 amRNSKromek awarded further $748K contract by DARPA
22nd Feb 20167:00 amRNSSole source supplier contract from DARPA
18th Feb 20164:05 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSCapital Markets Day
20th Jan 20167:00 amRNSNew contract with long-standing customer
22nd Dec 201511:29 amRNSDirector Share Purchase
16th Dec 20157:00 amRNSDirectorate Changes
16th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSKromek enters partnership with CANBERRA Industries
5th Nov 20157:00 amRNSCross Licensing Agreement
23rd Oct 201512:49 pmRNSResult of AGM
8th Oct 20157:00 amRNSDARPA Sole Source Notice
30th Sep 20151:53 pmRNSNotice of AGM and Posting of Annual Report
28th Sep 20152:18 pmRNSBlocklisting Interim Review
28th Sep 20157:00 amRNSAppointment of Sir Peter Williams CBE as Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.